ARTICLE | Clinical News
Rebif: Began Phase II/III trial
October 4, 1993 7:00 AM UTC
Ares-Serono Group Product: Rebif, recombinant beta interferon Indication: Treat relapsing-remitting multiple sclerosis Status: Began Phase II/III trial in Europe and plans to initiate Phase II/III tr...